Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
Regulatory Approvals
Belumosudil Phase 3 Results Expected
Belumosudil • Lung Transplant Rejection
Target Indication
Lung Transplant Rejection
Clinical Trial
Last updated: 12/4/2025
Rezurock
Treatment of chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic therapy.
SAN.PA
Sanofi
